Krista Ann Ross

Aviation safety and security: Canadian Aviation Regulations ( CARs ), Canadian Aviation Security Regulations (CASRs), Canadian Aviation Security Screening Airport Investment Statement – Lease Extension Implementation Enhancing the traveller journey - the evolving role of technology and innovations in the airport experience The needs of the modern Canadian airport system - Financial support for regional air service, protection of Canada’s airspace from interference, and funding support for airport infrastructure Transportation Modernization Act - implementing certain aspects of the proposed legislation Short term relief and long term economic recovery for Canada’s Airports as a result of the impacts of COVID-19 CBSA services at air borders - with respect to CBSA resources Canadian Air Transport Security Authority Act - with respect to implementing commitments made in Transportation 2030 Bill C-52: with regards to service level standards, noise, environmental reporting, and diversity. Bilateral Trade and Air Service Agreements - general support for increased or expanded bilateral air agreements for Canada. Observer or neutral party for information purposes at discussions Airport Rent, Fees and Taxes - with respect to reforms to airport rent Airport Capital Assistance Program - program eligibility

To recommend policies that will attract increased investment in the pharmaceutical and well being industry, such as on policies, research programs and policies and the Innovation Agenda. To actively promote the value of the pharmaceutical industry for Canada's economic health and well being, but more importantly for the health and well being of its citizens and to propose solutions for integrated health care in Canada. To actively promote the enhancement of publicly funded women’s health initiatives/programs. Representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in Canada. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the drug plans administered by the Federal Government and to emphasize the importance that the federal government respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.

Policies and programs related to gender equality and girls' rights in international development, humanitarian crises and foreign affairs Policies in regards to the foreign affairs for consideration of children rights in wars. Policies, programmes and funding issues related to Aboriginal Affairs, specifically in the areas of climate change and emergency response. International Development Assistance policies and funding across the development and humanitarian spectrum General policies, programmes and funding allocations related to Global Climate Justice